rHuEpo treatment in low-risk myelodysplastic syndromes.
Laffan
M
M
Vassiliou
G
G
D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin